A quiet signal inside a tumor may soon guide how surgeons treat early lung cancer. Researchers now report that hidden genetic ...

From 2019 to 2024, there was an increase in early lung cancer detection and decrease in local/advanced diagnosis.

A new study co-led by the Institute for Systems Biology (ISB) shows that some lung cancers can change identity as they evolve ...

Physicians remain “cautiously optimistic” about using AI in lung cancer care, with many seeing the potential but trust is conditional, according to a presenter at European Lung Cancer ...

MethylScan is a low-cost blood test that detects multiple cancers and liver diseases by analyzing DNA methylation patterns ...

DELFI Diagnostics to showcase whole-genome cfDNA platform advances in cancer detection and monitoring at AACR 2026 meeting: Palo Alto, California Wednesday, April 8, 2026, 15:00 H ...

Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths - around 1.8 million lives lost each year.

Natera, Inc. (NASDAQ: NTRA) a global leader in cell-free DNA and precision medicine, today announced that 20 abstracts, including two oral presentations, featuring data generated using its ...

Scientists have developed a simple and cost-effective blood test that shows promise for detecting multiple cancers, various ...

Five poster presentations span lung cancer early detection, immunotherapy response prediction, cancer subtyping, treatment monitoring, and next-generation ...

UCLA scientists have developed a simple and cost-effective blood test that, in early studies, shows promise in detecting multiple cancers, various ...

Abstract: The Lung cancer remains to abundant as a leading reason of cancer-associated death worldwide, which necessitates early recognition for increasing survival rates. Standard diagnostic ...